IMNCI Laos vs. Drug Guide & Medication Utilizzo e statistiche

IMNCI Laos App has been developed by the Murdoch Children’s Research Institute (MCRI), UNICEF, Ministry of Health Laos, Lao Pediatric Association, Luxembourg Aid & Development & Curve Tomorrow. IMNCI Laos App, based on the IMNCI Guidelines, is aimed at strengthening the management of neonatal & childhood illnesses by equipping healthcare workers in Laos with information that is easily accessible & friendly to use from their mobile phones. Reference: World Health Organization. (n.d.). Integrated Management of Childhood Illness. World Health Organization. Retrieved March 7, 2023, from https://www.who.int/teams/maternal-newborn-child-adolescent-health-and-ageing/child-health/integrated-management-of-childhood-illness

App Store di Apple
Gratis
Settore Medico

Classifica degli store

- -

Drug Guide & Medication

Information for Consumers and Patients App contains info about all drugs approved by the U.S. Food and Drug Administration (FDA). You can choose an analogue of the brand name for the active ingredient and dosage form, as well as according to the pharm classes. Information for Health Care Professionals Descriptions all drugs include medication guides with details on pharmacokinetics, dosing, side effects, interactions, assessment, and more. You can explore hepatotoxicity each medicine by the LiverTox Database. In-App subscriptions include: - access to all current features and info about pharm classes (by mechanism of action [MoA] or established pharmacologic class [EPC]) each medicine; - cloud bookmarks and notes (use the app on multiple iPhones or iPads). If you have any feature requests, suggestions or you simply need help, please email us hda.feedback@gmail.com . Terms of Use: https://sites.google.com/view/hdatermsofuse/index Privacy Policy: https://sites.google.com/view/hdaprivacypolicy/index THIS APP DOES NOT OFFER MEDICAL ADVICE, AND NOTHING CONTAINED IN THE CONTENT IS INTENDED TO CONSTITUTE PROFESSIONAL ADVICE FOR MEDICAL DIAGNOSIS OR TREATMENT